Peritoneal dialysis: is it time to move to DOACs?

30 August 2024 (12:36 - 12:48)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Mrs Sandra Burja Piko

University Medical Centre Maribor, Maribor (Slovenia)

4 More presentations in this session

Presentation thumbnail

Angiotensin receptor-neprilysin inhibition in patients with end-stage kidney disease and refractory hypertension

Doctor C. HUANG (Taipei, TW)

Presentation thumbnail

At the intersection of ischemic and bleeding risk – What type-2 myocardial infarction unveils in young patient with HIV infection and uterine fibroma

Doctor M. Iurascu-Botezatu (Bucharest, RO)

Presentation thumbnail

Thrombotic odyssey: navigating the challenges in a complex medical case

Doctor A. Stoica (Bucharest, RO)

Presentation thumbnail

Systemic sclerosis/ polymyositis (SSC/ PM) overlap syndrome induced cardiomyopathy in the context of renal crisis- a diagnostic dilemma

Doctor A. Karthik (Preston, GB)

Access the full session

Session thumbnail

Challenges with cardiovascular comorbidities

The Event

Event poster

ESC Congress 2024

30 August 2024 12:36 CET

You may be interested in

Congress Presentation

Comparing the efficacy and safety of DOACs with VKAs in patients with end-stage kidney disease on dialysis and non-valvular atrial fibrillation: a systematic review and meta-analysis

Congress Presentation

Impact of real-world off-label dose of apixaban on long-term clinical outcomes in heart failure patients with atrial fibrillation and end stage kidney disease

Congress Presentation

Apixaban vs. warfarin for venous thromboembolism in renal impairment: a meta-analysis of efficacy and safety

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources